patient_id,dataset,bilateral_breast_cancer,multifocal_cancer,nac_agent,endocrine_therapy,anti_her2_neu_therapy,pcr,mastectomy_post_nac,days_to_follow_up,days_to_recurrence,days_to_metastasis,days_to_death,hr,er,pr,her2,mammaprint,oncotype_score,nottingham_grade,tumor_subtype,age,menopause,ethnicity,has_implant,weight,patient_size,bmi_group,view,bilateral_mri,num_phases,fat_suppressed,field_strength,image_rows,image_columns,num_slices,pixel_spacing,slice_thickness,site,manufacturer,scanner_model,high_bit,window_center,window_width,echo_time,repetition_time,acquisition_times,acquisition_date,tcia_series_uid
DUKE_061,DUKE,0,1.0,,0.0,0.0,1.0,1.0,188.0,0.0,,220.0,,0.0,0.0,0.0,,,high,TripleNeg,59.0,post,african american,0,71.0,,overweight,axial,1,4,1,1.5,512,512,174,"[0.6641, 0.6641]",1.0,,GE,Optima MR450w ,15,475.0,951.0,2.516,5.38,"[0, 268, 385, 502]",,1.3.6.1.4.1.14519.5.2.1.108872398847262229983257156206321964740
ISPY2_426106,ISPY2,0,1.0,Paclitaxel + MK-2206,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,56.0,post,caucasian,0,,,,axial,0,6,1,3.0,512,512,132,"[0.8398, 0.8398]",2.4,AAN ,GE,Signa HDxt,15,377.0,755.0,2.664,5.959,"[0, 97, 194, 292, 389, 487]",2001/03/03,1.3.6.1.4.1.14519.5.2.1.321085042972622563212931724524559849896
ISPY2_668752,ISPY2,0,0.0,Paclitaxel + Pembrolizumab,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,58.0,peri (6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,61.23,,normal,axial,0,6,1,3.0,512,512,134,"[0.6641, 0.6641]",2.4,AAN ,GE,DISCOVERY MR750 ,15,445.0,891.0,4.82,9.12,"[0, 96, 193, 289, 386, 482]",2004/07/11,1.3.6.1.4.1.14519.5.2.1.119371481798364839967873329107766677017
ISPY2_515281,ISPY2,0,1.0,Paclitaxel + Ganitumab,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,46.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,84.0,,obesity_class_1,axial,0,7,1,1.5,512,512,66,"[0.6055, 0.6055]",2.4,AAV ,GE,Signa HDxt,15,372.0,745.0,2.996,6.232,"[0, 138, 227, 315, 403, 492, 580]",2002/11/07,1.3.6.1.4.1.14519.5.2.1.102642110825396566290852702764272339106
ISPY2_494946,ISPY2,0,0.0,Paclitaxel + Pembrolizumab,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,51.0,post,caucasian,0,63.64,,normal,axial,0,9,1,1.5,512,512,80,"[0.703125, 0.703125]",2.0,AAB ,SIEMENS,Avanto,11,76.0,196.0,1.81,4.33,"[0, 138, 218, 298, 378, 457, 537, 617, 777]",2004/06/18,1.3.6.1.4.1.14519.5.2.1.249715107793304330906103835429704827593
ISPY2_406190,ISPY2,0,0.0,Paclitaxel + Neratinib,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,54.0,post,caucasian,0,73.0,1.54,obesity_class_1,axial,1,8,1,3.0,384,384,72,"[0.9375, 0.9375]",2.5,AAF ,SIEMENS,Verio ,11,102.0,230.0,1.37,4.32,"[0, 761, 841, 921, 1001, 1081, 1161, 1241]",2000/02/02,1.3.6.1.4.1.14519.5.2.1.177009568716101742305330303497357698483
ISPY2_478484,ISPY2,0,0.0,Paclitaxel + Neratinib,,,0.0,,,,,,0.0,,,0.0,0.0,,,TripleNeg,64.0,post,asian,0,48.081,,underweight,axial,0,8,1,1.5,512,512,80,"[0.5664, 0.5664]",2.0,AAI ,GE,Signa HDxt,15,136.0,272.0,2.728,6.772,"[0, 296, 389, 481, 572, 666, 759, 853]",1998/11/21,1.3.6.1.4.1.14519.5.2.1.153422719431703627345792021455418463623
DUKE_114,DUKE,0,1.0,,0.0,0.0,0.0,0.0,2198.0,0.0,,0.0,,1.0,1.0,0.0,,7.0,intermediate,Luminal,49.0,pre,caucasian,0,81.647,,overweight,axial,1,4,1,3.0,512,512,182,"[0.7031, 0.7031]",1.0,,GE,Signa HDxt,15,800.0,1600.0,2.388,5.383,"[0, 214, 326, 438]",,1.3.6.1.4.1.14519.5.2.1.144688254078604001896200551902427916650
ISPY1_1157,ISPY1,0,,,,,0.0,,1521.0,0.0,,0.0,,0.0,0.0,1.0,,,,HER2pos,41.0,,caucasian,0,86.183,,obesity_class_1,sagittal,0,3,1,1.5,256,256,60,"[0.976562, 0.976562]",2.8,Site AAI,GE,GENESIS_SIGNA ,15,7.0,15.0,4.2,8.9,"[0, 397, 736]",1987/05/22,1.3.6.1.4.1.14519.5.2.1.7695.1700.244449122403775217180477825193
DUKE_176,DUKE,0,1.0,,0.0,0.0,0.0,0.0,822.0,935.0,,0.0,,1.0,1.0,0.0,,,,Luminal,45.0,pre,caucasian,0,106.5942205095,,obesity_class_2,axial,1,5,1,1.5,320,320,160,"[1.1875, 1.1875]",1.2000000476837,,SIEMENS,Avanto,11,44.0,120.0,1.47,4.26,"[0, 343, 460, 577, 694]",,1.3.6.1.4.1.14519.5.2.1.201210793494871077243051896979379421549
DUKE_454,DUKE,0,0.0,,0.0,0.0,0.0,0.0,1154.0,0.0,,0.0,,1.0,1.0,0.0,,,high,Luminal,58.0,post,african american,0,74.3891581428,1.6510033041667,overweight,axial,1,4,1,1.5,448,448,176,"[0.71428573131561, 0.71428573131561]",1.0,,SIEMENS,Avanto,11,118.0,240.0,1.39,4.37,"[0, 222, 341, 465]",,1.3.6.1.4.1.14519.5.2.1.294649750503562535731773141938052803088
ISPY2_172283,ISPY2,0,1.0,Paclitaxel + Neratinib,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,48.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),african american,0,77.0,,overweight,axial,0,9,1,3.0,384,384,64,"[0.9375, 0.9375]",2.5,AAF ,SIEMENS,Verio ,11,40.0,109.0,1.37,4.32,"[0, 354, 434, 514, 594, 674, 754, 834, 922]",1999/11/25,1.3.6.1.4.1.14519.5.2.1.149744437796523021247024662636208677262
ISPY2_947398,ISPY2,0,1.0,T-DM1 + Pertuzumab,,,1.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,44.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,70.307,,overweight,axial,0,8,1,1.5,512,512,80,"[0.6641, 0.6641]",2.0,AAI ,GE,Signa HDxt,15,109.0,219.0,4.2,7.0,"[0, 152, 239, 326, 413, 500, 587, 674]",2001/08/04,1.3.6.1.4.1.14519.5.2.1.7695.4164.323951350026853395352416803833
ISPY2_924868,ISPY2,0,1.0,Paclitaxel + Ganetespib,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,56.0,post,caucasian,0,72.258,,overweight,axial,0,8,1,1.5,512,512,80,"[0.703125, 0.703125]",2.0,AAB ,SIEMENS,Avanto,11,83.0,216.0,1.81,4.33,"[0, 146, 226, 306, 386, 466, 546, 625]",2003/07/12,1.3.6.1.4.1.14519.5.2.1.159377336292398418601832247224333526996
ISPY2_269899,ISPY2,0,0.0,Paclitaxel + Ganetespib,,,1.0,,,,,,1.0,,,0.0,0.0,,,Luminal,58.0,,caucasian,0,108.86,,obesity_class_2,axial,0,6,1,3.0,512,512,134,"[0.8203, 0.8203]",2.4,AAN ,GE,DISCOVERY MR750w,15,465.0,931.0,4.572,8.736,"[0, 96, 192, 288, 384, 481]",2002/12/17,1.3.6.1.4.1.14519.5.2.1.7695.4164.271233500273350909336693600568
ISPY2_831702,ISPY2,0,0.0,T-DM1 + Pertuzumab,,,0.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,42.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),asian,0,78.925,,overweight,axial,0,6,1,3.0,512,512,134,"[0.7422, 0.7422]",2.4,AAN ,GE,Signa HDxt,15,210.0,420.0,2.752,6.878,"[0, 97, 194, 291, 389, 486]",2003/07/02,1.3.6.1.4.1.14519.5.2.1.253338346685594243796374816470996580110
ISPY2_775346,ISPY2,0,1.0,Paclitaxel,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,35.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,60.328,,normal,axial,0,8,1,1.5,512,512,80,"[0.5859, 0.5859]",2.0,AAI ,GE,Signa HDxt,15,231.0,462.0,4.2,7.012,"[0, 248, 336, 423, 510, 597, 685, 772]",2001/03/10,1.3.6.1.4.1.14519.5.2.1.7695.4164.262158279078532098068545049568
ISPY2_239061,ISPY2,0,0.0,Paclitaxel + Ganitumab,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,70.0,post,african american,0,74.843,,overweight,axial,1,7,1,1.5,512,512,200,"[0.625, 0.625]",1.6,AAU ,GE,Signa HDxt,15,176.0,352.0,2.208,4.612,"[0, 196, 392, 588, 784, 980, 1176]",2001/02/18,1.3.6.1.4.1.14519.5.2.1.72011184624700888321512279668274167531
ISPY2_962153,ISPY2,0,0.0,Paclitaxel + AMG 386 + Trastuzumab,,,0.0,,,,,,1.0,,,1.0,1.0,,,HER2pos,55.0,,caucasian,0,68.039,,normal,axial,0,6,1,3.0,512,512,134,"[0.6836, 0.6836]",2.4,AAN ,GE,Signa HDxt,15,235.0,471.0,2.824,7.529,"[0, 97, 194, 291, 388, 485]",2002/06/14,1.3.6.1.4.1.14519.5.2.1.7695.4164.790924212298108033115240995690
ISPY2_240035,ISPY2,0,1.0,Paclitaxel + Ganetespib,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,68.0,post,caucasian,0,89.811,,obesity_class_1,axial,0,8,1,1.5,512,512,80,"[0.6445, 0.6445]",2.0,AAO ,GE,Signa HDxt,15,480.0,1175.0,2.62,5.842,"[0, 143, 237, 332, 426, 521, 615, 710]",2003/06/20,1.3.6.1.4.1.14519.5.2.1.94155324268556595817837760667759068570
ISPY2_287961,ISPY2,0,1.0,Paclitaxel + MK-2206 + Trastuzumab,,,1.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,53.0,post,caucasian,0,52.163,,normal,axial,0,6,1,3.0,512,512,134,"[0.625, 0.625]",2.4,AAN ,GE,Signa HDxt,15,392.0,784.0,4.25,8.55,"[0, 97, 195, 292, 390, 487]",2002/06/14,1.3.6.1.4.1.14519.5.2.1.7695.4164.200663038968967427579175901551
ISPY2_326202,ISPY2,0,0.0,Paclitaxel + Pembrolizumab,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,45.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),asian,0,61.23,,normal,axial,0,6,1,3.0,512,512,134,"[0.6641, 0.6641]",2.4,AAN ,GE,DISCOVERY MR750 ,15,271.0,542.0,2.676,5.509,"[0, 112, 208, 304, 400, 496]",2004/09/29,1.3.6.1.4.1.14519.5.2.1.332195371490273040816795867009194516081
ISPY2_830958,ISPY2,0,1.0,Paclitaxel + Pembrolizumab,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,55.0,,african american,0,88.904,,obesity_class_1,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,184.0,368.0,4.236,8.668,"[0, 113, 203, 292, 381, 471, 560]",2004/07/03,1.3.6.1.4.1.14519.5.2.1.63770984727829818286900657113539919928
ISPY2_242370,ISPY2,0,0.0,Paclitaxel + Pembrolizumab,,,1.0,,,,,,1.0,,,0.0,0.0,,,Luminal,38.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,86.183,,obesity_class_1,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,287.0,574.0,4.236,8.668,"[0, 114, 204, 293, 382, 472, 561]",2004/05/14,1.3.6.1.4.1.14519.5.2.1.49376630704757265447308336397913070598
ISPY2_539876,ISPY2,0,0.0,Paclitaxel + Ganetespib,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,59.0,post,caucasian,0,87.09,,obesity_class_1,axial,0,8,1,1.5,512,512,80,"[0.5469, 0.5469]",2.0,AAO ,GE,Signa HDxt,15,358.0,717.0,2.756,7.149,"[0, 141, 239, 337, 436, 534, 633, 731]",2003/02/05,1.3.6.1.4.1.14519.5.2.1.7867658972562638938841335565410026756
ISPY2_178815,ISPY2,0,1.0,Paclitaxel + Neratinib,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,39.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,58.967,,normal,axial,0,8,1,1.5,512,512,80,"[0.5859, 0.5859]",2.0,AAI ,GE,Signa HDxt,15,167.0,335.0,4.2,7.0,"[0, 217, 310, 402, 495, 587, 680, 772]",2000/05/06,1.3.6.1.4.1.14519.5.2.1.115801642238390583244328966782734444714
ISPY2_357034,ISPY2,0,1.0,Paclitaxel + Ganetespib,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,63.0,,caucasian,0,75.0,,overweight,axial,0,7,1,1.5,512,512,64,"[0.6641, 0.6641]",2.5,AAX ,GE,Optima MR450w ,15,206.0,413.0,2.528,5.353,"[0, 157, 256, 354, 453, 551, 650]",2003/06/07,1.3.6.1.4.1.14519.5.2.1.233442563363290150015588928992075329111
ISPY2_962827,ISPY2,0,0.0,Paclitaxel + Ganitumab,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,37.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,6,1,3.0,512,512,120,"[0.7031, 0.7031]",2.4,AAN ,GE,Signa HDxt,15,247.0,494.0,2.796,7.247,"[0, 97, 195, 292, 389, 486]",2001/03/24,1.3.6.1.4.1.14519.5.2.1.62319075332352580318588541786571982624
ISPY2_627118,ISPY2,0,1.0,Paclitaxel + Trastuzumab,,,0.0,,,,,,0.0,,,1.0,0.0,,,HER2pos,44.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,58.06,,normal,axial,0,8,1,1.5,512,512,80,"[0.625, 0.625]",2.0,AAI ,GE,Signa HDxt,15,104.0,209.0,2.644,6.025,"[0, 278, 371, 464, 557, 648, 738, 830]",1999/02/20,1.3.6.1.4.1.14519.5.2.1.196155521324199825950279438190277149866
ISPY2_474874,ISPY2,0,1.0,Paclitaxel + Pertuzumab + Trastuzumab,,,1.0,,,,,,0.0,,,1.0,0.0,,,HER2pos,41.0,,caucasian,0,76.204,,overweight,axial,0,7,1,3.0,512,512,80,"[0.5859, 0.5859]",2.0,AAK ,GE,Signa HDxt,15,403.0,806.0,2.18,5.447,"[0, 126, 217, 309, 402, 493, 585]",2002/11/14,1.3.6.1.4.1.14519.5.2.1.7695.4164.179610764136871073786498450462
ISPY1_1009,ISPY1,0,,,,,0.0,,2355.0,0.0,,0.0,,0.0,0.0,0.0,,,,TripleNeg,40.0,,asian,0,52.617,,normal,sagittal,0,3,1,1.5,256,256,60,"[0.78125, 0.78125]",2.0,Site AAI,GE,GENESIS_SIGNA ,15,15.0,31.0,4.2,8.4,"[0, 382, 776]",1985/03/16,1.3.6.1.4.1.14519.5.2.1.7695.1700.471625799765630092122359693714
ISPY2_824234,ISPY2,0,1.0,Paclitaxel + Trastuzumab,,,1.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,30.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,8,1,1.5,512,512,80,"[0.5859, 0.5859]",2.0,AAO ,GE,Signa HDxt,15,283.0,566.0,2.696,6.589,"[0, 119, 217, 316, 414, 513, 611, 710]",2002/03/13,1.3.6.1.4.1.14519.5.2.1.172469670732997603356158043429756475735
ISPY2_741535,ISPY2,0,0.0,Paclitaxel,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,33.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,8,1,1.5,512,512,80,"[0.5273, 0.5273]",2.0,AAO ,GE,Signa HDxt,15,349.0,698.0,2.18,5.667,"[0, 101, 176, 251, 326, 401, 476, 551]",2002/11/08,1.3.6.1.4.1.14519.5.2.1.187244859130109809007428203961816240513
ISPY2_640463,ISPY2,0,0.0,Paclitaxel + ABT 888 + Carboplatin,,,1.0,,,,,,1.0,,,0.0,1.0,,,Luminal,31.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,95.6898585476,1.676403355,obesity_class_1,axial,1,7,1,1.5,256,256,160,"[1.328125, 1.328125]",1.25,AAJ ,SIEMENS,Avanto,11,178.0,398.0,1.41,4.99,"[0, 120, 211, 303, 394, 485, 576]",1999/11/24,1.3.6.1.4.1.14519.5.2.1.311875959407099051699499138590860757922
ISPY2_910188,ISPY2,0,0.0,Paclitaxel + Ganitumab,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,64.0,post,caucasian,0,73.0193090111,,overweight,axial,1,7,1,1.5,384,384,176,"[0.8333333135, 0.8333333135]",1.1000000238,AAJ ,SIEMENS,Avanto,11,250.0,580.0,1.52,4.14,"[0, 122, 219, 318, 415, 512, 610]",2001/06/30,1.3.6.1.4.1.14519.5.2.1.49495885604787408389026974430853007874
ISPY2_122287,ISPY2,0,1.0,T-DM1 + Pertuzumab,,,1.0,,,,,,1.0,,,1.0,1.0,,,HER2pos,54.0,post,caucasian,0,61.0,,normal,axial,0,7,1,1.5,560,560,160,"[0.600961566, 0.600961566]",2.0,AAG ,Philips,Intera,11,978.0,1701.0,2.657,5.3903,"[0, 109, 201, 293, 385, 477, 569]",2003/05/24,1.3.6.1.4.1.14519.5.2.1.128903129139775904393892511677212602059
ISPY1_1189,ISPY1,0,,,,,1.0,,1314.0,0.0,,0.0,,0.0,0.0,1.0,,,,HER2pos,68.0,,asian,0,48.988,,underweight,sagittal,0,3,1,1.5,256,256,60,"[0.9375, 0.9375]",2.3,Site AAI,GE,GENESIS_SIGNA ,15,113.0,227.0,4.2,8.9,"[0, 477, 781]",1987/11/22,1.3.6.1.4.1.14519.5.2.1.7695.1700.337684541400077102072707800970
ISPY2_356684,ISPY2,0,0.0,Paclitaxel + AMG 386 + Trastuzumab,,,0.0,,,,,,1.0,,,1.0,1.0,,,HER2pos,51.0,post,hawaiian/pacific islander,0,83.915,,obesity_class_1,axial,0,6,1,3.0,512,512,150,"[0.7227, 0.7227]",2.4,AAN ,GE,Signa HDxt,15,155.0,310.0,2.78,7.078,"[0, 97, 195, 292, 390, 487]",2001/11/04,1.3.6.1.4.1.14519.5.2.1.183502276803299279512985256047807513850
DUKE_077,DUKE,0,0.0,,0.0,0.0,0.0,0.0,1702.0,0.0,,0.0,,0.0,0.0,0.0,,,,TripleNeg,38.0,pre,caucasian,0,67.132,,normal,axial,1,5,1,3.0,512,512,174,"[0.6836, 0.6836]",1.0,,GE,SIGNA HDx ,15,1016.0,2033.0,2.4,5.519,"[0, 139, 351, 467, 583]",,1.3.6.1.4.1.14519.5.2.1.164065338920500492667606880117873369290
ISPY2_378885,ISPY2,0,0.0,Paclitaxel + AMG 386,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,36.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,70.3068262935,,overweight,axial,1,7,1,1.5,384,384,160,"[0.78125, 0.78125]",1.0,AAW ,SIEMENS,Avanto,11,92.0,248.0,2.37,5.15,"[0, 120, 210, 300, 390, 480, 570]",2001/07/29,1.3.6.1.4.1.14519.5.2.1.7695.4164.266298627685242960599984503043
DUKE_694,DUKE,0,0.0,,0.0,0.0,0.0,1.0,1408.0,0.0,,0.0,,1.0,1.0,0.0,,,intermediate,Luminal,44.0,pre,caucasian,0,74.84,,overweight,axial,1,4,1,1.5,512,512,174,"[0.7031, 0.7031]",1.0,,GE,Optima MR450w ,15,466.0,933.0,2.476,5.34,"[0, 181, 298, 414]",,1.3.6.1.4.1.14519.5.2.1.193861872180133913350062392118676104600
ISPY2_622315,ISPY2,0,0.0,Paclitaxel + AMG 386,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,48.0,,caucasian,0,73.028,,overweight,axial,0,7,1,1.5,512,512,66,"[0.5859, 0.5859]",2.4,AAV ,GE,Signa HDxt,15,937.0,1875.0,3.02,6.244,"[0, 145, 233, 322, 410, 499, 587]",2001/07/13,1.3.6.1.4.1.14519.5.2.1.103020516141278807806829636327854485452
ISPY2_290413,ISPY2,0,0.0,Paclitaxel + AMG 386 + Trastuzumab,,,0.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,59.0,post,caucasian,0,80.0,1.75,overweight,axial,1,9,1,3.0,384,384,72,"[0.9375, 0.9375]",2.5,AAF ,SIEMENS,Verio ,11,164.0,372.0,1.37,4.32,"[0, 144, 224, 304, 384, 464, 544, 624, 762]",2001/12/27,1.3.6.1.4.1.14519.5.2.1.100452425741100080366779934343547691209
ISPY1_1128,ISPY1,0,,,,,0.0,,1684.0,0.0,,0.0,,1.0,0.0,1.0,,,,HER2pos,33.0,,caucasian,0,56.699,,normal,sagittal,0,3,1,1.5,256,256,60,"[0.78125, 0.78125]",2.0,Site AAI,GE,GENESIS_SIGNA ,15,52.0,104.0,4.2,8.9,"[0, 385, 724]",1986/12/14,1.3.6.1.4.1.14519.5.2.1.7695.1700.153118239290774109071783184800
ISPY2_333145,ISPY2,0,0.0,Paclitaxel + Pembrolizumab,,,1.0,,,,,,1.0,,,0.0,1.0,,,Luminal,49.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,7,1,1.5,512,512,80,"[0.6641, 0.6641]",2.0,AAX ,GE,Optima MR450w ,15,201.0,402.0,2.548,5.288,"[0, 154, 252, 350, 448, 546, 644]",2004/11/04,1.3.6.1.4.1.14519.5.2.1.323353133596446817883724245472903381351
ISPY2_834418,ISPY2,0,0.0,Paclitaxel,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,59.0,post,caucasian,0,,,,axial,0,8,1,1.5,512,512,90,"[0.7031, 0.7031]",2.0,AAO ,GE,Signa HDxt,15,341.0,682.0,2.56,5.267,"[0, 121, 208, 295, 382, 469, 556, 643]",2002/01/18,1.3.6.1.4.1.14519.5.2.1.33952148543639054496022846321155953836
ISPY2_146987,ISPY2,0,0.0,Paclitaxel + AMG 386,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,53.0,post,asian,0,68.492,,overweight,axial,0,8,1,1.5,512,512,80,"[0.6836, 0.6836]",2.0,AAI ,GE,Signa HDxt,15,107.0,214.0,4.2,7.0,"[0, 182, 269, 356, 443, 530, 617, 704]",2002/01/03,1.3.6.1.4.1.14519.5.2.1.7695.4164.808316711296205042450496878785
DUKE_623,DUKE,0,1.0,,0.0,0.0,0.0,1.0,1683.0,0.0,,0.0,,1.0,1.0,0.0,,,,Luminal,56.0,pre,african american,0,95.254,,obesity_class_1,axial,1,5,1,3.0,512,512,196,"[0.7813, 0.7813]",1.1,,GE,SIGNA HDx ,15,783.0,1566.0,2.332,5.068,"[0, 176, 295, 415, 534]",,1.3.6.1.4.1.14519.5.2.1.285260020089602884273109914822435006072
ISPY2_628692,ISPY2,0,1.0,Paclitaxel + Neratinib,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,58.0,post,caucasian,0,83.915,,obesity_class_1,axial,0,7,1,1.5,512,512,80,"[0.625, 0.625]",2.0,AAI ,GE,SIGNA HDx ,15,173.0,347.0,2.644,5.897,"[0, 340, 429, 513, 597, 682, 769]",1998/08/27,1.3.6.1.4.1.14519.5.2.1.96657266384457902735018012218845355275
ISPY2_614044,ISPY2,0,1.0,Paclitaxel,,,0.0,,,,,,0.0,,,0.0,0.0,,,TripleNeg,52.0,,african american,0,63.0493474503,,normal,axial,0,8,1,1.5,512,512,80,"[0.703125, 0.703125]",2.0,AAB ,SIEMENS,Avanto,11,70.0,193.0,1.67,4.51,"[0, 236, 321, 406, 491, 576, 661, 746]",2000/09/01,1.3.6.1.4.1.14519.5.2.1.67460297100428349168905674834880075954
ISPY2_591079,ISPY2,0,0.0,Paclitaxel + Ganetespib,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,43.0,,caucasian,0,80.739,,overweight,axial,0,7,1,3.0,512,512,80,"[0.625, 0.625]",2.0,AAK ,GE,Signa HDxt,15,362.0,725.0,2.14,5.01,"[0, 120, 222, 324, 427, 529, 631]",2003/05/24,1.3.6.1.4.1.14519.5.2.1.311082425073139961571381066097230651907
ISPY1_1099,ISPY1,0,,,,,1.0,,1769.0,0.0,,0.0,,0.0,0.0,0.0,,,,TripleNeg,50.0,,caucasian,0,62.596,,normal,sagittal,0,3,1,1.5,256,256,60,"[0.78125, 0.78125]",2.0,Site AAI,GE,GENESIS_SIGNA ,15,8.0,17.0,4.2,8.9,"[0, 456, 767]",1986/09/12,1.3.6.1.4.1.14519.5.2.1.7695.1700.213462325359469755577407645202
DUKE_142,DUKE,0,0.0,,0.0,0.0,1.0,0.0,1462.0,0.0,,0.0,,0.0,1.0,0.0,,,high,Luminal,49.0,pre,caucasian,0,42.6376882038,1.52400305,underweight,axial,1,4,1,1.5,448,448,176,"[0.71428573131561, 0.71428573131561]",1.0,,SIEMENS,Avanto,11,168.0,620.0,1.39,4.37,"[0, 213, 331, 461]",,1.3.6.1.4.1.14519.5.2.1.30422836382945420699403683165949607265
ISPY2_623086,ISPY2,0,0.0,Paclitaxel + Neratinib,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,34.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,8,1,1.5,512,512,80,"[0.7422, 0.7422]",2.0,AAO ,GE,Signa HDxt,15,271.0,543.0,2.528,5.184,"[0, 197, 282, 368, 454, 540, 626, 712]",2000/03/11,1.3.6.1.4.1.14519.5.2.1.31596144519286210632976751176723111514
DUKE_834,DUKE,0,1.0,,0.0,1.0,1.0,0.0,1406.0,0.0,,0.0,,1.0,0.0,1.0,,,,HER2pos,53.0,pre,caucasian,0,80.739,,overweight,axial,1,5,1,3.0,512,512,166,"[0.7031, 0.7031]",1.0,,GE,SIGNA HDx ,15,649.0,1299.0,2.388,5.374,"[0, 323, 431, 538, 646]",,1.3.6.1.4.1.14519.5.2.1.74479981516231667069851916423047437142
ISPY2_233191,ISPY2,0,1.0,Paclitaxel,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,42.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,56.699,,normal,axial,0,8,1,1.5,512,512,80,"[0.6445, 0.6445]",2.0,AAI ,GE,Signa HDxt,15,98.0,196.0,4.2,7.0,"[0, 171, 259, 346, 433, 520, 607, 694]",2001/07/07,1.3.6.1.4.1.14519.5.2.1.7695.4164.325210015330961883241147923248
ISPY2_493472,ISPY2,0,1.0,Paclitaxel + Ganetespib,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,66.0,post,caucasian,0,63.502939878,1.6002032025,normal,axial,0,7,1,3.0,512,512,124,"[0.5859375, 0.5859375]",1.2999999523,AAW ,SIEMENS,Prisma_fit,11,68.0,187.0,1.82,4.72,"[0, 120, 211, 301, 392, 482, 572]",2003/11/09,1.3.6.1.4.1.14519.5.2.1.68753260332469059213114530878831205507
ISPY1_1163,ISPY1,0,,,,,1.0,,1280.0,0.0,,0.0,,0.0,0.0,0.0,,,,TripleNeg,38.0,,caucasian,0,72.575,,overweight,sagittal,0,3,1,1.5,256,256,56,"[0.703125, 0.703125]",2.5,Site AAE,GE,GENESIS_SIGNA ,15,35.0,71.0,4.2,9.0,"[0, 279, 520]",1987/07/12,1.3.6.1.4.1.14519.5.2.1.7695.1700.175283820372330840199174328565
DUKE_610,DUKE,0,1.0,,0.0,1.0,0.0,1.0,3121.0,0.0,,0.0,,1.0,1.0,1.0,,,intermediate,HER2pos,53.0,post,caucasian,0,67.132,,normal,axial,1,5,1,3.0,512,512,178,"[0.6836, 0.6836]",1.2,,GE,SIGNA HDx ,15,579.0,1159.0,2.4,5.379,"[0, 492, 670, 798, 927]",,1.3.6.1.4.1.14519.5.2.1.68107268530454791824813505202239038611
ISPY2_335536,ISPY2,0,0.0,Paclitaxel + AMG 386,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,67.0,,african american,0,,,,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,217.0,435.0,4.236,8.668,"[0, 111, 200, 290, 379, 468, 557]",2002/04/27,1.3.6.1.4.1.14519.5.2.1.7695.4164.452894772534001963515718104729
ISPY2_128051,ISPY2,0,0.0,T-DM1 + Pertuzumab,,,0.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,56.0,post,caucasian,0,90.0,,obesity_class_1,axial,0,7,1,1.5,512,512,160,"[0.64453125, 0.64453125]",2.0,AAQ ,Philips,Achieva ,11,393.0,684.0,3.546,7.1877,"[0, 87, 175, 262, 350, 437, 525]",2003/05/23,1.3.6.1.4.1.14519.5.2.1.228301790254849422259810987083179785285
DUKE_507,DUKE,0,1.0,,0.0,0.0,1.0,0.0,2243.0,0.0,,0.0,,1.0,0.0,0.0,,,high,Luminal,59.0,post,african american,0,90.718,,obesity_class_1,axial,1,5,1,3.0,512,512,176,"[0.7422, 0.7422]",1.0,,GE,SIGNA HDx ,15,1071.0,2142.0,2.36,5.136,"[0, 330, 439, 548, 657]",,1.3.6.1.4.1.14519.5.2.1.227958074115057760223378286615750997398
ISPY2_884011,ISPY2,0,0.0,Paclitaxel + Ganitumab,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,66.0,post,caucasian,0,63.503,,normal,axial,0,8,1,1.5,512,512,80,"[0.6445, 0.6445]",2.0,AAI ,GE,Signa HDxt,15,111.0,223.0,4.2,7.0,"[0, 195, 283, 370, 457, 544, 631, 719]",2001/10/13,1.3.6.1.4.1.14519.5.2.1.7695.4164.176985702410853745944802958204
ISPY2_706418,ISPY2,0,0.0,T-DM1 + Pertuzumab,,,1.0,,,,,,0.0,,,1.0,1.0,,,HER2pos,59.0,post,caucasian,0,74.0,,overweight,axial,0,7,1,1.5,512,512,64,"[0.6641, 0.6641]",2.5,AAX ,GE,Optima MR450w ,15,297.0,595.0,2.528,5.354,"[0, 140, 238, 337, 435, 534, 633]",2003/04/18,1.3.6.1.4.1.14519.5.2.1.146800144137496539816564009248392111071
ISPY2_797639,ISPY2,0,1.0,Paclitaxel + MK-2206,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,57.0,post,caucasian,0,,,,axial,0,8,1,1.5,512,512,90,"[0.5664, 0.5664]",2.0,AAO ,GE,Signa HDxt,15,288.0,577.0,2.728,6.846,"[0, 126, 221, 316, 411, 506, 601, 696]",2001/05/16,1.3.6.1.4.1.14519.5.2.1.206814839387991606441555831151606739966
ISPY2_131961,ISPY2,0,1.0,T-DM1 + Pertuzumab,,,1.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,44.0,,caucasian,0,56.7,,normal,axial,0,6,1,3.0,512,512,134,"[0.6641, 0.6641]",2.4,AAN ,GE,DISCOVERY MR750w,15,498.0,997.0,4.7,8.952,"[0, 97, 193, 289, 385, 481]",2002/12/18,1.3.6.1.4.1.14519.5.2.1.7695.4164.180862518195496282786165278422
DUKE_217,DUKE,0,0.0,,0.0,0.0,1.0,1.0,1575.0,0.0,,0.0,,0.0,0.0,0.0,,,,TripleNeg,50.0,pre,african american,0,42.638,,underweight,axial,1,5,1,3.0,512,512,142,"[0.5469, 0.5469]",1.0,,GE,SIGNA HDx ,15,872.0,1744.0,2.56,6.978,"[0, 209, 330, 450, 571]",,1.3.6.1.4.1.14519.5.2.1.212128607048870032902541405073501949218
ISPY2_803514,ISPY2,0,0.0,Paclitaxel,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,55.0,post,caucasian,0,,,,axial,0,6,1,3.0,512,512,134,"[0.7813, 0.7813]",2.4,AAN ,GE,Signa HDxt,15,239.0,478.0,2.72,6.516,"[0, 97, 195, 293, 391, 490]",2000/08/30,1.3.6.1.4.1.14519.5.2.1.170917341805467204684730160926830108753
ISPY2_602943,ISPY2,0,1.0,Paclitaxel,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,38.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,53.5239064686,,normal,axial,1,8,1,1.5,384,384,144,"[0.8072916667, 0.8072916667]",1.2000000477,AAL ,SIEMENS,Symphony,11,40.0,108.0,1.72,4.58,"[0, 90, 150, 210, 270, 330, 390, 450]",1998/12/16,1.3.6.1.4.1.14519.5.2.1.71151040901947746708130799125492966461
ISPY2_783427,ISPY2,0,0.0,Paclitaxel,,,1.0,,,,,,1.0,,,0.0,1.0,,,Luminal,34.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,77.0,,overweight,axial,1,7,1,1.5,400,400,72,"[0.8999999762, 0.8999999762]",2.5,AAA ,Philips,Achieva ,11,74.22,128.98,2.598,5.208,"[0, 109, 192, 275, 359, 442, 525]",2001/09/26,1.3.6.1.4.1.14519.5.2.1.9775453652324259887844007235121616465
DUKE_762,DUKE,0,0.0,,0.0,0.0,0.0,0.0,367.0,381.0,,572.0,,0.0,0.0,0.0,,,,TripleNeg,34.0,pre,asian,0,68.039,,normal,axial,1,5,1,1.5,512,512,184,"[0.625, 0.625]",1.0,,GE,SIGNA HDx ,15,455.0,911.0,2.352,4.964,"[0, 542, 658, 773, 889]",,1.3.6.1.4.1.14519.5.2.1.152752842064657111146799735354037025771
ISPY2_795996,ISPY2,0,1.0,Paclitaxel + Pertuzumab + Trastuzumab,,,1.0,,,,,,1.0,,,1.0,1.0,,,HER2pos,47.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,90.718,,obesity_class_1,axial,0,6,1,3.0,512,512,134,"[0.7813, 0.7813]",2.4,AAN ,GE,Signa HDxt,15,200.0,401.0,2.712,6.475,"[0, 98, 195, 292, 389, 486]",2002/10/24,1.3.6.1.4.1.14519.5.2.1.7695.4164.140743979247984447696060822130
ISPY2_493519,ISPY2,0,1.0,Paclitaxel,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,40.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,1,7,1,1.5,384,384,160,"[0.7291666865, 0.7291666865]",1.0,AAR ,SIEMENS,SymphonyTim ,11,64.0,172.0,1.81,5.05,"[0, 97, 194, 291, 388, 485, 583]",2002/04/13,1.3.6.1.4.1.14519.5.2.1.94903468844665751025004522992765216934
ISPY2_712917,ISPY2,0,0.0,Paclitaxel + Ganetespib,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,45.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,79.379,,overweight,axial,0,8,1,1.5,512,512,78,"[0.5664, 0.5664]",2.0,AAO ,GE,Signa HDxt,15,305.0,611.0,2.728,6.812,"[0, 127, 212, 296, 381, 465, 550, 634]",2003/01/11,1.3.6.1.4.1.14519.5.2.1.269065408079406228068535910241212651185
ISPY2_941191,ISPY2,0,1.0,Paclitaxel + Neratinib,,,0.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,52.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,6,1,3.0,512,512,134,"[0.7031, 0.7031]",2.4,AAN ,GE,Signa HDxt,15,366.0,732.0,2.808,7.312,"[0, 97, 195, 292, 390, 487]",1999/10/02,1.3.6.1.4.1.14519.5.2.1.21841919512702115986907764700632610066
ISPY1_1012,ISPY1,0,,,,,0.0,,2425.0,2425.0,,0.0,,1.0,1.0,0.0,,,,Luminal,53.0,,african american,0,84.822,,obesity_class_1,sagittal,0,3,1,1.5,256,256,60,"[0.859375, 0.859375]",2.1,Site AAI,GE,GENESIS_SIGNA ,15,25.0,50.0,4.2,8.4,"[0, 380, 727]",1985/03/30,1.3.6.1.4.1.14519.5.2.1.7695.1700.135796154808190999296545278795
ISPY2_953262,ISPY2,1,0.0,Paclitaxel + Neratinib,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,36.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,107.6193393961,,obesity_class_2,axial,1,7,1,1.5,256,256,160,"[1.2890625, 1.2890625]",1.1499999762,AAJ ,SIEMENS,Avanto,11,75.0,205.0,1.42,4.99,"[0, 145, 239, 339, 432, 525, 618]",2000/07/28,1.3.6.1.4.1.14519.5.2.1.239227025666020628855280680537956855458
ISPY2_180663,ISPY2,1,1.0,Paclitaxel + MK-2206,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,39.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,1,80.3901859613,,overweight,axial,1,7,1,1.5,384,384,176,"[0.859375, 0.859375]",1.1000000238,AAJ ,SIEMENS,Avanto,11,166.0,280.0,1.51,4.12,"[0, 131, 230, 326, 423, 521, 617]",2001/05/04,1.3.6.1.4.1.14519.5.2.1.232444557273771199775418437315995169213
ISPY2_688291,ISPY2,0,0.0,Paclitaxel + AMG 386,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,56.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,81.647,,overweight,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,224.0,448.0,4.28,8.744,"[0, 127, 217, 307, 398, 488, 578]",2002/08/28,1.3.6.1.4.1.14519.5.2.1.7695.4164.236100018857950335152866966382
DUKE_107,DUKE,0,1.0,,0.0,0.0,0.0,0.0,1632.0,0.0,,0.0,,0.0,0.0,0.0,,,,TripleNeg,65.0,post,african american,0,102.058,,obesity_class_2,axial,1,5,1,3.0,512,512,196,"[0.7617, 0.7617]",1.0,,GE,SIGNA HDx ,15,1809.0,3618.0,2.348,5.14,"[0, 228, 349, 470, 591]",,1.3.6.1.4.1.14519.5.2.1.231033412235707795811509606682702677256
ISPY2_261304,ISPY2,0,1.0,Paclitaxel + Ganitumab,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,49.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,8,1,1.5,512,512,80,"[0.5664, 0.5664]",2.0,AAO ,GE,Signa HDxt,15,265.0,531.0,2.728,6.822,"[0, 153, 243, 333, 422, 512, 601, 691]",2002/11/29,1.3.6.1.4.1.14519.5.2.1.80535454032807597490916964106243612513
ISPY2_361701,ISPY2,0,0.0,Paclitaxel + MK-2206,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,49.0,post,caucasian,0,,,,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,234.0,468.0,4.236,8.668,"[0, 204, 293, 382, 472, 561, 650]",2001/07/21,1.3.6.1.4.1.14519.5.2.1.7695.4164.168863346352258240830589607785
DUKE_002,DUKE,0,0.0,,0.0,0.0,0.0,0.0,1649.0,0.0,,0.0,,0.0,0.0,0.0,,,high,TripleNeg,38.0,pre,african american,0,,,,axial,1,4,1,3.0,512,512,142,"[0.5859, 0.5859]",1.3,,GE,Signa HDxt,15,326.0,652.0,2.704,6.918,"[0, 165, 288, 411]",,1.3.6.1.4.1.14519.5.2.1.292087950444413314643924739363083325442
ISPY1_1032,ISPY1,0,,,,,0.0,,1384.0,,,,,1.0,1.0,0.0,,,,Luminal,37.0,,asian,0,56.699,,normal,sagittal,0,3,1,1.5,256,256,60,"[0.78125, 0.78125]",2.0,Site AAI,GE,GENESIS_SIGNA ,15,21.0,42.0,4.2,8.4,"[0, 436, 791]",1985/07/25,1.3.6.1.4.1.14519.5.2.1.7695.1700.922720171377625332664550712681
DUKE_506,DUKE,0,0.0,,0.0,0.0,0.0,0.0,1442.0,0.0,,0.0,,1.0,1.0,0.0,,,,Luminal,45.0,post,african american,0,88.4505234015,,obesity_class_1,axial,1,5,1,3.0,448,448,144,"[0.75892859697342, 0.75892859697342]",1.0999999046326,,SIEMENS,TrioTim ,11,299.0,606.0,1.44,4.09,"[0, 206, 317, 428, 538]",,1.3.6.1.4.1.14519.5.2.1.274610027268536476810338444459766647450
ISPY2_504838,ISPY2,0,1.0,Paclitaxel,,,0.0,,,,,,0.0,,,0.0,0.0,,,TripleNeg,69.0,,caucasian,0,,,,axial,1,7,1,1.5,384,384,160,"[0.7291666865, 0.7291666865]",1.0,AAR ,SIEMENS,SymphonyTim ,11,62.0,166.0,1.81,5.05,"[0, 97, 194, 291, 389, 486, 583]",2002/08/01,1.3.6.1.4.1.14519.5.2.1.97145253647716488039321793442562227868
ISPY1_1168,ISPY1,0,,,,,0.0,,345.0,308.0,,345.0,,0.0,0.0,0.0,,,,TripleNeg,44.0,,caucasian,0,65.317,,normal,sagittal,0,3,1,1.5,256,256,60,"[0.976562, 0.976562]",2.3,Site AAI,GE,GENESIS_SIGNA ,15,11.0,23.0,4.2,8.4,"[0, 497, 747]",1987/08/10,1.3.6.1.4.1.14519.5.2.1.7695.1700.200892389682105974273914096193
DUKE_005,DUKE,0,1.0,,0.0,1.0,1.0,1.0,1845.0,0.0,,0.0,,1.0,0.0,1.0,,,high,HER2pos,38.0,pre,hispanic,0,54.431091324,1.6256032533333,normal,axial,1,4,1,1.5,448,448,160,"[0.78125, 0.78125]",1.0,,SIEMENS,Avanto,11,106.0,288.0,1.34,4.27,"[0, 183, 289, 398]",,1.3.6.1.4.1.14519.5.2.1.308267282790822635275517329397281651993
DUKE_304,DUKE,0,1.0,,0.0,0.0,0.0,1.0,1231.0,0.0,,0.0,,1.0,1.0,0.0,,15.0,,Luminal,60.0,post,caucasian,0,70.7604187212,,overweight,axial,1,5,1,1.5,320,320,160,"[1.125, 1.125]",1.1000000238419,,SIEMENS,Avanto,11,47.0,128.0,1.5,4.26,"[0, 187, 308, 431, 553]",,1.3.6.1.4.1.14519.5.2.1.218109054655311975468169371746789803316
ISPY2_284443,ISPY2,0,0.0,Paclitaxel + AMG 386 + Trastuzumab,,,0.0,,,,,,1.0,,,1.0,0.0,,,HER2pos,46.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,63.503,,normal,axial,0,8,1,1.5,512,512,80,"[0.6641, 0.6641]",2.0,AAI ,GE,Signa HDxt,15,106.0,212.0,4.2,7.0,"[0, 204, 291, 378, 465, 552, 639, 726]",2001/07/14,1.3.6.1.4.1.14519.5.2.1.7695.4164.297700313996930496623002501230
DUKE_636,DUKE,0,0.0,,0.0,0.0,0.0,1.0,1421.0,0.0,,0.0,,0.0,0.0,0.0,,,,TripleNeg,61.0,post,caucasian,0,95.254,,obesity_class_1,axial,1,5,1,3.0,512,512,152,"[0.6836, 0.6836]",1.0,,GE,SIGNA HDx ,15,668.0,1336.0,2.416,5.525,"[0, 219, 322, 426, 529]",,1.3.6.1.4.1.14519.5.2.1.282796868066108574464430787500966086119
DUKE_530,DUKE,0,1.0,,0.0,0.0,0.0,1.0,1412.0,0.0,,0.0,,1.0,1.0,0.0,,,,Luminal,45.0,post,asian,0,73.482,,overweight,axial,1,5,1,1.5,512,512,174,"[0.6641, 0.6641]",1.0,,GE,Signa HDxt,15,284.0,568.0,2.312,4.924,"[0, 189, 292, 395, 498]",,1.3.6.1.4.1.14519.5.2.1.118657742176361981909152761665581432878
NACT_59,NACT,0,0.0,Anthracycline,,,0.0,0.0,2935.0,0.0,0.0,,,1.0,1.0,0.0,,,,Luminal,45.0,,,0,68.039,,normal,sagittal,0,3,1,1.5,256,256,60,"[0.703125, 0.703125]",2.0,4493,GE,GENESIS_SIGNA ,15,,,4.2,8.2,"[0, 389, 705]",1991/06/13,1.3.6.1.4.1.14519.5.2.1.7695.2311.102930174665051601227388951639
ISPY2_916645,ISPY2,0,1.0,Paclitaxel,,,1.0,,,,,,1.0,,,0.0,0.0,,,Luminal,50.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,75.296,,overweight,axial,0,8,1,1.5,512,512,80,"[0.6641, 0.6641]",2.0,AAI ,GE,Signa HDxt,15,105.0,211.0,4.2,7.0,"[0, 300, 416, 508, 601, 693, 786, 878]",2000/04/13,1.3.6.1.4.1.14519.5.2.1.317127813349296851638702023818152753969
ISPY2_542392,ISPY2,0,1.0,Paclitaxel + Ganitumab,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,56.0,post,caucasian,0,94.3472249616,,obesity_class_1,axial,1,7,1,1.5,384,384,160,"[0.8854166865, 0.8854166865]",1.0,AAR ,SIEMENS,SymphonyTim ,11,48.0,132.0,1.81,5.05,"[0, 97, 194, 291, 389, 486, 583]",2001/04/14,1.3.6.1.4.1.14519.5.2.1.158486215425832639688260320733569787899
DUKE_595,DUKE,0,0.0,,0.0,0.0,0.0,0.0,1446.0,0.0,,0.0,,1.0,1.0,0.0,,,intermediate,Luminal,47.0,post,caucasian,0,90.71848554,1.7526035075,overweight,axial,1,4,1,1.5,448,448,160,"[0.75892859697342, 0.75892859697342]",1.0,,SIEMENS,Avanto,11,71.0,179.0,1.36,4.31,"[0, 251, 356, 463]",,1.3.6.1.4.1.14519.5.2.1.186439455194053573201157723932171706398
ISPY2_462582,ISPY2,0,1.0,Paclitaxel,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,55.0,post,caucasian,0,74.389,,overweight,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,276.0,552.0,4.236,8.668,"[0, 122, 211, 301, 390, 479, 568]",2002/10/19,1.3.6.1.4.1.14519.5.2.1.7695.4164.215380931801316243937726685615
ISPY2_661730,ISPY2,0,0.0,Paclitaxel + AMG 386,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,39.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,,,,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,233.0,466.0,4.28,8.744,"[0, 110, 200, 290, 380, 470, 560]",2001/12/07,1.3.6.1.4.1.14519.5.2.1.7695.4164.217222029293398281186496421865
ISPY2_845783,ISPY2,0,0.0,Paclitaxel + AMG 386,,,1.0,,,,,,1.0,,,0.0,1.0,,,Luminal,34.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),african american,0,,,,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,224.0,448.0,4.236,8.668,"[0, 118, 207, 297, 386, 476, 565]",2001/08/24,1.3.6.1.4.1.14519.5.2.1.7695.4164.327418396862805206252123604032
NACT_45,NACT,0,0.0,Anthracycline,,,0.0,0.0,2068.0,2068.0,2068.0,,,1.0,1.0,0.0,,,,Luminal,49.0,,caucasian,0,72.575,,overweight,sagittal,0,3,1,1.5,256,256,60,"[0.703125, 0.703125]",2.0,4493,GE,GENESIS_SIGNA ,15,,,4.2,8.2,"[0, 381, 694]",1990/05/31,1.3.6.1.4.1.14519.5.2.1.7695.2311.241672653605066133403728212170
ISPY1_1088,ISPY1,0,,,,,1.0,,1967.0,0.0,,0.0,,1.0,1.0,0.0,,,,Luminal,53.0,,caucasian,0,68.946,,overweight,sagittal,0,3,1,1.5,256,256,60,"[0.78125, 0.78125]",2.0,Site AAI,GE,GENESIS_SIGNA ,15,12.0,25.0,4.2,8.9,"[0, 466, 783]",1986/08/01,1.3.6.1.4.1.14519.5.2.1.7695.1700.284641076219984766218952736499
ISPY2_419590,ISPY2,0,0.0,Paclitaxel + Ganetespib,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,63.0,post,african american,0,63.049,,normal,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,258.0,517.0,4.236,8.668,"[0, 136, 226, 315, 404, 494, 583]",2003/09/17,1.3.6.1.4.1.14519.5.2.1.60906869555150243376138703218770526260
ISPY2_726091,ISPY2,0,0.0,Paclitaxel + Neratinib,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,43.0,pre (< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,59.4115361801,,normal,axial,0,7,1,1.5,256,256,134,"[1.171875, 1.171875]",1.2000000477,AAJ ,SIEMENS,Avanto,11,72.0,190.0,1.45,4.99,"[0, 122, 215, 309, 402, 495, 588]",2000/10/01,1.3.6.1.4.1.14519.5.2.1.339470799048977354477459781217751965059
ISPY1_1209,ISPY1,0,,,,,0.0,,970.0,0.0,,0.0,,1.0,0.0,0.0,,,,Luminal,43.0,,caucasian,0,54.431,,normal,sagittal,0,3,1,1.5,256,256,56,"[0.703125, 0.703125]",2.5,Site AAE,GE,GENESIS_SIGNA ,15,29.0,58.0,4.199,9.0,"[0, 349, 683]",1988/02/13,1.3.6.1.4.1.14519.5.2.1.7695.1700.584776979131233369424887287054
ISPY2_628823,ISPY2,0,1.0,Paclitaxel + Ganitumab,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,42.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,120.202,,obesity_class_3,axial,0,7,1,1.5,512,512,76,"[0.8203, 0.8203]",2.2,AAE ,GE,Signa HDxt,15,269.0,538.0,4.12,8.46,"[0, 115, 203, 291, 378, 466, 553]",2002/11/14,1.3.6.1.4.1.14519.5.2.1.7695.4164.227117351763386977418978237759
NACT_12,NACT,0,0.0,Anthracycline + Taxane,,,0.0,1.0,804.0,804.0,804.0,,,,,,,,,,48.0,,caucasian,0,83.915,,obesity_class_1,sagittal,0,3,1,1.5,256,256,60,"[0.898438, 0.898438]",2.4,4493,GE,GENESIS_SIGNA ,15,94.0,188.0,4.2,8.4,"[0, 373, 698]",1994/02/14,1.3.6.1.4.1.14519.5.2.1.7695.2311.593636178993104967980816590394
ISPY1_1098,ISPY1,0,,,,,1.0,,1395.0,1095.0,,1395.0,,1.0,0.0,1.0,,,,HER2pos,62.0,,caucasian,0,77.0,,overweight,sagittal,0,6,1,1.5,256,256,60,"[0.78125, 0.78125]",4.0,Site AAG,Philips,Gyroscan Intera ,11,816.0,1633.0,6.3868,32.8576,,1986/09/19,1.3.6.1.4.1.14519.5.2.1.7695.1700.179421902361743959678818979795
ISPY2_459311,ISPY2,0,0.0,Paclitaxel + Ganetespib,,,0.0,,,,,,1.0,,,0.0,1.0,,,Luminal,54.0,,caucasian,0,92.986,,obesity_class_1,axial,0,7,1,1.5,512,512,72,"[0.7031, 0.7031]",2.2,AAE ,GE,Signa HDxt,15,155.0,310.0,4.236,8.668,"[0, 114, 203, 292, 382, 471, 560]",2003/10/15,1.3.6.1.4.1.14519.5.2.1.264601818335678142639847770967102800612
ISPY2_188700,ISPY2,0,0.0,Paclitaxel + Ganitumab,,,1.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,58.0,post,caucasian,0,66.0,,normal,axial,0,7,1,3.0,512,512,160,"[0.6701030731, 0.6701030731]",2.0,AAC ,Philips,Achieva ,11,1087.0,1889.0,1.787,4.0,"[0, 128, 226, 323, 418, 513, 610]",2001/12/22,1.3.6.1.4.1.14519.5.2.1.7695.4164.162817387329506691219174974714
ISPY2_621179,ISPY2,0,1.0,Paclitaxel + AMG 386,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,53.0,,caucasian,0,92.02,1.7,obesity_class_1,axial,1,7,1,1.5,384,384,176,"[0.8854166865, 0.8854166865]",1.1000000238,AAJ ,SIEMENS,Avanto,11,57.0,141.0,1.5,4.1,"[0, 124, 218, 315, 409, 503, 601]",2001/12/08,1.3.6.1.4.1.14519.5.2.1.89607890664551169017500328529264095426
ISPY2_780272,ISPY2,0,0.0,Paclitaxel + Ganitumab,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,54.0,post,caucasian,0,66.0,,normal,axial,0,7,1,1.5,512,512,180,"[0.703125, 0.703125]",2.0,AAG ,Philips,Intera,11,775.0,1348.0,2.814,5.4091,"[0, 154, 238, 322, 405, 489, 573]",2002/01/26,1.3.6.1.4.1.14519.5.2.1.288387167375273205637085392374820674220
ISPY2_530095,ISPY2,0,0.0,Paclitaxel + AMG 386,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,45.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),african american,0,68.4924565827,,overweight,axial,0,8,1,1.5,512,512,80,"[0.703125, 0.703125]",2.0,AAB ,SIEMENS,Avanto,11,65.0,178.0,1.67,4.51,"[0, 167, 252, 336, 417, 506, 590, 675]",2001/05/05,1.3.6.1.4.1.14519.5.2.1.7695.4164.623358079979882711063949076940
DUKE_645,DUKE,0,0.0,,0.0,0.0,1.0,1.0,1226.0,0.0,,0.0,,0.0,0.0,0.0,,,high,TripleNeg,25.0,pre,caucasian,0,,,,axial,1,4,1,3.0,448,448,208,"[0.78125, 0.78125]",1.0,,SIEMENS,Skyra ,15,64.0,177.0,1.44,3.77,"[0, 293, 415, 536]",,1.3.6.1.4.1.14519.5.2.1.70969430646484899849880135756782918029
ISPY2_127675,ISPY2,0,1.0,Paclitaxel + Neratinib,,,0.0,,,,,,0.0,,,0.0,0.0,,,TripleNeg,59.0,post,caucasian,0,,,,axial,0,6,1,3.0,512,512,134,"[0.7422, 0.7422]",2.4,AAN ,GE,Signa HDxt,15,195.0,390.0,2.76,6.868,"[0, 98, 196, 293, 391, 489]",1999/10/31,1.3.6.1.4.1.14519.5.2.1.260468579368946743169063784878306352225
ISPY2_492612,ISPY2,0,0.0,Paclitaxel,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,37.0,pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),caucasian,0,102.06,,obesity_class_2,axial,0,8,1,1.5,512,512,76,"[0.625, 0.625]",2.1,AAI ,GE,Signa HDxt,15,48.0,97.0,4.2,7.032,"[0, 176, 263, 349, 436, 523, 609, 696]",2004/10/14,1.3.6.1.4.1.14519.5.2.1.236248510547011863188627393454282154099
DUKE_395,DUKE,0,0.0,,0.0,1.0,0.0,0.0,1960.0,0.0,,0.0,,0.0,0.0,1.0,,,intermediate,HER2pos,48.0,pre,african american,0,63.503,,normal,axial,1,4,1,3.0,512,512,182,"[0.6641, 0.6641]",1.0,,GE,Signa HDxt,15,515.0,1030.0,2.42,5.665,"[0, 165, 281, 398]",,1.3.6.1.4.1.14519.5.2.1.258104756267376687417928327464469719541
ISPY2_293142,ISPY2,0,1.0,Paclitaxel,,,0.0,,,,,,1.0,,,0.0,0.0,,,Luminal,56.0,post,caucasian,0,83.007,,obesity_class_1,axial,0,7,1,3.0,512,512,66,"[0.7031, 0.7031]",2.4,AAK ,GE,Signa HDxt,15,127.0,255.0,2.1,4.304,"[0, 105, 200, 295, 390, 485, 580]",2001/11/21,1.3.6.1.4.1.14519.5.2.1.7695.4164.250755115409336616834403407239
ISPY2_462581,ISPY2,0,0.0,Paclitaxel + Ganetespib,,,0.0,,,,,,0.0,,,0.0,1.0,,,TripleNeg,69.0,post,african american,0,66.0,,normal,axial,0,9,1,3.0,416,416,64,"[0.8413461447, 0.8413461447]",2.5,AAF ,SIEMENS,Verio ,11,170.0,302.0,1.52,4.74,"[0, 473, 562, 651, 740, 829, 919, 1008, 1102]",2003/05/31,1.3.6.1.4.1.14519.5.2.1.196610055992408001467173762275960705711
ISPY1_1124,ISPY1,0,,,,,0.0,,1567.0,805.0,,0.0,,0.0,0.0,1.0,,,,HER2pos,47.0,,caucasian,0,84.0,,obesity_class_1,sagittal,0,6,1,1.5,256,256,60,"[0.78125, 0.78125]",4.0,Site AAG,Philips,Intera,11,1521.0,3281.0,6.2528,32.8576,,1986/12/11,1.3.6.1.4.1.14519.5.2.1.7695.1700.122673880464686628051847045718
